journal article·2005-01-14

Principle of a New Immunoassay Based on Electrophoretic Mobility of Poly(styrene/α‐tert‐butoxy‐ω‐vinylbenzyl‐polyglycidol) Microspheres: Application for the Determination of Helicobacter pylori IgG in Blood Serum

Teresa Basinska, Monika Wisniewska, Magdalena Chmiela

Macromolecular Bioscience· Volume 5· Issue 1
Publisher page

Abstract

Abstract Summary: The principle of a novel latex diagnostic test for the determination of antibodies against Helicobacter pylori in blood sera is described. The test is based on the measurement of the electrophoretic mobility of the microspheres with immobilized H. pylori antigens. The electrophoretic mobility of these microspheres depends on the concentration of the antibodies against H. pylori in suspending medium. Particles with hydrophilic polyglycidol in the surface layer were used for the test. The microspheres were obtained by an emulsifier‐free emulsion copolymerization of styrene and α‐tert‐butoxy‐ω‐vinylbenzyl‐polyglycidol macromonomer ($\overline D \rm n$ = 220 nm, diameter polydispersity factor $\overline D \rm w /\overline D \rm n$ = 1.02). Activation of polyglycidol hydroxyl groups with cyanuric chloride allowed for covalent immobilization of H. pylori antigens. The fraction of H. pylori not specifically adsorbed onto the microspheres was negligible. Changes of the electrophoretic mobility of the microspheres with the surface concentration of the covalently immobilized H. pylori antigens Γ = (1.6 ± 0.3) · 10−3 g m−2 were suitable for the detection of the antibodies in the sera of patients with titer in the range (determined by the indirect ELISA test) from 1:500 to 1:32 000. image
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Glycosylation and Glycoproteins Research · Helicobacter pylori-related gastroenterology studies · Veterinary medicine and infectious diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (26)

Show source-provided references
1. 10.1002/(SICI)1099-1581(199609)7:9<749::AID-PAT550>3.0.CO;2-010.1002/(SICI)1099-1581(199609)7:9<749::AID-PAT550>3.0.CO;2-0 ↗
2. 10.1006/jcis.1993.119010.1006/jcis.1993.1190 ↗
3. 10.1021/bc00014a01510.1021/bc00014a015 ↗
4. 10.1007/s00396010051710.1007/s003960100517 ↗
5. 10.1007/3-540-16422-7_610.1007/3-540-16422-7_6 ↗
6. 10.1163/15685620275341927710.1163/156856202753419277 ↗
7. Slomkowski S. · Biocybernetics Biomed. Eng. · 2001 · 21 · 49
8. 10.1021/bm034288710.1021/bm0342887 ↗
9. 10.1128/CMR.10.4.72010.1128/CMR.10.4.720 ↗
10. Hoek F. J. · J. Clin. Microbiol. · 1992 · 30 · 152510.1128/jcm.30.6.1525-1528.1992 ↗
11. 10.1007/BF0200545710.1007/BF02005457 ↗
12. Westblom T. U. · J. Clin. Microbiol. · 1992 · 30 · 9610.1128/jcm.30.1.96-98.1992 ↗
13. 10.1007/s10096005046910.1007/s100960050469 ↗
14. Lozniewski A. · J. Clin. Microbiol. · 1996 · 34 · 177310.1128/jcm.34.7.1773-1775.1996 ↗
15. Meijer B. C. · J. Clin. Microbiol. · 1997 · 35 · 29210.1128/jcm.35.1.292-294.1997 ↗
16. 10.1016/S0016-5085(97)80020-010.1016/S0016-5085(97)80020-0 ↗
17. 10.1007/BF0196166210.1007/BF01961662 ↗
18. 10.1007/s00289005027710.1007/s002890050277 ↗
19. 10.1016/S0079-6700(97)00053-110.1016/S0079-6700(97)00053-1 ↗
20. 10.1111/j.1348-0421.1997.tb01869.x10.1111/j.1348-0421.1997.tb01869.x ↗
21. Logan S. M. · Inf. Immun. · 1983 · 42 · 67510.1128/iai.42.2.675-682.1983 ↗
22. Lowry O. H. · J. Biochem. · 1951 · 193 · 265
23. 10.1163/156856291X0022310.1163/156856291X00223 ↗
24. Allen R. C. · 1994 · 111
25. Basinska T. · e‐Polymers · 2002 · 011
26. 10.1002/pat.28310.1002/pat.283 ↗